PRECISION BIOSCIENCES INC — Director's Dealing 2020

Apr 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2020-04-14

Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-14	Common Stock	M	4392	$1.18	Acquired	3862738	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-14	Employee Stock Option (Right to Buy)	$1.18	M	4392	Acquired	2027-03-23	Common Stock (4392)	Direct

Footnotes

F1: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of the each successive three-month period over the 36 months following such date.